Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems-Reference-Cited by-同舟云学术

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Published:2010-10 Issue:43 Volume:28 Page:7016-7024
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Leroux-Roels Isabel,Koutsoukos Marguerite,Clement Frédéric,Steyaert Sophia,Janssens Michel,Bourguignon Patricia,Cohen Kristen,Altfeld Marcus,Vandepapelière Pierre,Pedneault Louise,McNally Lisa,Leroux-Roels Geert,Voss Gerald

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference60 articles.

1. AIDS epidemic update: November 2009;UNAIDS,2009

2. Scientific and policy challenges to development of an AIDS vaccine;Berkley;Lancet,2007

3. HIV vaccine design and the neutralizing antibody problem;Burton;Nat Immunol,2004

4. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;Rerks-Ngarm;N Engl J Med,2009

5. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication;Walker;Science,1986

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial;The Lancet Rheumatology;2024-06

2. Safety and immunogenicity of a DNA vaccine with subtype C gp120 protein adjuvanted with MF59® or AS01B: a phase 1/2a HIV-1 vaccine trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-03

3. Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects;Viruses;2024-02-27

4. A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses;Science Translational Medicine;2023-05-24

5. Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus;Pharmacological Reports;2022-09-20